ZGN:NYSEErmenegildo Zegna N.V. Analysis
Data as of 2026-09-01 - not real-time
$13.58
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Ermenegildo Zegna N.V. is bullish at $13.58, with short-term averages leading the long-term ones. Across the trailing 30 sessions it lost 2.3%. With RSI at 42.6 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $13.00 and resistance around $15.95.
On valuation the read is fair — an earnings multiple of 30.9, absent a reliable peer benchmark. The average analyst target implies 10.1% above today's level. The 1.00% dividend yield looks covered by current payout levels.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 30.6%, a beta of 1.30 and a maximum drawdown of 21.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
On valuation the read is fair — an earnings multiple of 30.9, absent a reliable peer benchmark. The average analyst target implies 10.1% above today's level. The 1.00% dividend yield looks covered by current payout levels.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 30.6%, a beta of 1.30 and a maximum drawdown of 21.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Top Market Events
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting...Ermenegildo Zegna N.V. NYSE:ZGN the "Company" and, together with its consolidated subsidiaries, the "Ermenegildo Zegna...Seeking Alpha1monErmenegildo Zegna N.V. ZGN Q2 2026 Sales/Trading Call TranscriptGood afternoon, good morning,...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 11.91
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 11.91
- Analyst targets imply +10.1% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Analyst targets imply +10.1% versus the current price
- P/E ratio of 30.9
- Dividend yield of 1.00%
Key Metrics & Analysis
Financial Health
Revenue Growth0.30%
Profit Margin5.14%
P/E Ratio30.9
ROE10.52%
ROA3.59%
Debt/Equity89.38
P/B Ratio3.1
Op. Cash Flow$335.6M
Free Cash Flow$246.6M
Technical Analysis
TrendBullish
RSI42.6
Support$13.00
Resistance$15.95
MA 20$14.12
MA 50$13.88
MA 200$11.91
MACDBearish
VolumeStable
Fear & Greed Index94.79
Valuation
Fair Value$9.29
Target Price$14.95
Upside/Downside10.06%
GradeFair
TypeBlend
Dividend Yield1.00%
Risk Assessment
Beta1.30
Volatility30.63%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.